Cargando…

Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)

Detalles Bibliográficos
Autores principales:	Tuon, Felipe Francisco, Santos, Carolina Rocio, Cieslinski, Juliette, de Souza, Regina Maia, Imamura, Rui, Amato, Valdir Sabbaga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223253/ https://www.ncbi.nlm.nih.gov/pubmed/30427406 http://dx.doi.org/10.1590/S1678-9946201860071

Ejemplares similares

Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study
por: Santos, Carolina Rocio, et al.
Publicado: (2019)

USEFULNESS OF kDNA PCR IN THE DIAGNOSIS OF VISCERAL LEISHMANIASIS REACTIVATION IN CO-INFECTED PATIENTS
por: Nicodemo, Antonio Carlos, et al.
Publicado: (2013)

Facial Structure Alterations and Abnormalities of the Paranasal Sinuses on Multidetector Computed Tomography Scans of Patients with Treated Mucosal Leishmaniasis
por: de Camargo, Raphael Abegão, et al.
Publicado: (2014)

(18)F-FDG PET/CT in the Follow-Up of Mucosal Leishmaniasis
por: Camargo, Raphael A., et al.
Publicado: (2018)

Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα
por: Nicodemo, Antonio Carlos, et al.
Publicado: (2017)

Estimation of Leishmania spp. infection in asymptomatic people from Muzaffarpur, Bihar, India by antigen-antibody and skin testing
por: Johanson, Gustavo Henrique, et al.
Publicado: (2020)

Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review
por: Telles, João Paulo, et al.
Publicado: (2019)

Could kDNA-PCR in Peripheral Blood Replace the Examination of Bone Marrow for the Diagnosis of Visceral Leishmaniasis?
por: de Godoy, Natalia Souza, et al.
Publicado: (2016)

Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?
por: de Souza, Regina Maia, et al.
Publicado: (2017)

Vancomycin trough level and loading dose
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

Comparison of intermittent versus continuous-infusion vancomycin for treating severe patients in intensive care units
por: Yamada, Carolina Hikari, et al.
Publicado: (2020)

Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review
por: Trindade, Maria Angela Bianconcini, et al.
Publicado: (2015)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Ocular Leishmaniasis Treated by Intralesional Amphotericin B
por: Nikandish, Malihe, et al.
Publicado: (2016)

Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis
por: Chivinski, Jeffrey, et al.
Publicado: (2023)

Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol
por: Naeem, Faheel, et al.
Publicado: (2021)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Efficacy of Intralesional Amphotericin B for the Treatment of Cutaneous Leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2014)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

Detection of Microorganisms in Clinical Sonicated Orthopedic Devices Using Conventional Culture and qPCR
por: Ribeiro, Victoria Stadler Tasca, et al.
Publicado: (2021)

Evaluation of in vitro activity of ceftolozane–tazobactam against recent clinical bacterial isolates from Brazil – the EM200 study
por: Tuon, Felipe Francisco, et al.
Publicado: (2020)

Sonication as a tool for disrupting biofilms and recovering microorganisms in bladder catheters
por: Cieslinski, Juliette, et al.
Publicado: (2023)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021)

Auricular leishmaniasis in a child successfully treated with intralesional amphotericin B
por: Diociaiuti, Andrea, et al.
Publicado: (2022)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

Microbiological Identification and Susceptibility Testing Using an Automated Method in a Tertiary-Care Public Hospital in Brazil
por: Midori, Valeria, et al.
Publicado: (2021)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020)

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
por: Shahnaz, Gul, et al.
Publicado: (2017)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India
por: Fakiola, Michaela, et al.
Publicado: (2019)

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis
por: Riezk, Alaa, et al.
Publicado: (2020)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2021)

Voice Disorders in Mucosal Leishmaniasis
por: Ruas, Ana Cristina Nunes, et al.
Publicado: (2014)

Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
por: Cuna, Washington R., et al.
Publicado: (2007)

962. Cutaneous Leishmaniasis: Investigating Skin Drug Levels to Optimize Liposomal Amphotericin Dosing
por: Aronson, Naomi E, et al.
Publicado: (2018)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
por: Hasnain, Md Golam, et al.
Publicado: (2018)

Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis
por: Ren, Danfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9g86qhr8u35tcv5uam0sg90p5q